GLP-1 Providers in Maryland (2026)

362 of the 444 sellers that publish a state list include Maryland, the 11th-most of the 50 states and DC. 226 of them ship to all 50 states, and 6 serve 15 states or fewer. Across the 248 with a regular monthly price, the middle figure is $170/mo.

Maryland Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered without a prior authorization.

Sellers and prices are broken out by drug on the semaglutide in Maryland and tirzepatide in Maryland pages.

Who Ships GLP-1s to Maryland

1. WellMedRx $49/mo
2. Collective $59/mo
3. CoreAge Rx $79/mo

Lowest regular prices for Maryland: WellMedRx at $49/mo, Collective at $59/mo and CoreAge Rx at $79/mo.

Smaller-footprint sellers that include Maryland: TD Tele-Doc Weight Loss (2 states), Rivas Medical Weight Loss (3 states), Enara Health (5 states), OlleveCare (13 states) and Invite Wellness (14 states), plus 1 more.

2 sellers that list 30 or more states leave Maryland off, among them Welm Health and Care Clinics.

Seller counts next door: District of Columbia 118, Delaware 347, Pennsylvania 363, Virginia 365 and West Virginia 333.

Browse by medication

Maryland Medicaid and GLP-1 Coverage

Maryland Medicaid does not pay for GLP-1 drugs prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes are covered without a prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (Age 18 or older, prescribed by or with a cardiologist, BMI 27 or higher within 90 days, no diabetes of either type, and established heart disease: a prior heart attack, a prior stroke, or symptomatic peripheral artery disease (ABI under 0.85, revascularization or amputation). Not with another GLP-1).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2/F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30).
• Weight-loss GLP-1s for adolescents: not covered.

In 2025, Maryland Medicaid paid for at least 148,487 GLP-1 prescriptions, including at least 101,266 for Ozempic, at least 1,140 for Wegovy, at least 18,446 for Mounjaro and at least 1,909 for Zepbound, about $142.7 million before manufacturer rebates. Drugs labeled for weight loss made up 2% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Maryland

Maryland has 1,137 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 18.15 per 100,000 residents (1st of 51). By specialty: 530 bariatric, 605 endocrinology and 16 obesity medicine. About 32.7% of adults here had obesity in 2024 (CDC), the 31st-highest rate of the 50 states and DC. Measured against the median state, Maryland has 0.45 times as much adult obesity per specialist practice.

Largest Cities in Maryland

Frequently Asked Questions